Free Trial
NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Price, News & Analysis

Pulse Biosciences logo
$15.54 -0.02 (-0.13%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$16.02 +0.48 (+3.12%)
As of 08/29/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pulse Biosciences Stock (NASDAQ:PLSE)

Key Stats

Today's Range
$15.31
$15.76
50-Day Range
$14.71
$17.31
52-Week Range
$13.77
$25.00
Volume
91,586 shs
Average Volume
168,640 shs
Market Capitalization
$1.05 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00
Consensus Rating
Buy

Company Overview

Pulse Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
79th Percentile Overall Score

PLSE MarketRank™: 

Pulse Biosciences scored higher than 79% of companies evaluated by MarketBeat, and ranked 211th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pulse Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pulse Biosciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about Pulse Biosciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pulse Biosciences is -14.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pulse Biosciences is -14.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pulse Biosciences has a P/B Ratio of 10.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pulse Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    19.44% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 14.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently increased by 0.41%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Pulse Biosciences does not currently pay a dividend.

  • Dividend Growth

    Pulse Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    19.44% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 14.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently increased by 0.41%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Pulse Biosciences has a news sentiment score of 1.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.05 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Pulse Biosciences this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for PLSE on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pulse Biosciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $246,000.00 in company stock.

  • Percentage Held by Insiders

    71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pulse Biosciences' insider trading history.
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PLSE Stock News Headlines

New Banking Law #1582 Could Unlock $21 Trillion for Americans
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
See More Headlines

PLSE Stock Analysis - Frequently Asked Questions

Pulse Biosciences' stock was trading at $17.41 on January 1st, 2025. Since then, PLSE stock has decreased by 10.7% and is now trading at $15.54.

Pulse Biosciences, Inc (NASDAQ:PLSE) announced its quarterly earnings data on Tuesday, August, 12th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.02.
Read the conference call transcript
.

Pulse Biosciences (PLSE) raised $20 million in an initial public offering (IPO) on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

Top institutional investors of Pulse Biosciences include Bank of America Corp DE (1.16%), Geode Capital Management LLC (0.74%), Griffin Asset Management Inc. (0.34%) and Westside Investment Management Inc. (0.10%). Insiders that own company stock include Robert W Duggan, Darrin Uecker, Mitchell E Levinson, Mitchell E Levinson, Burke Thomas Barrett and Kevin Patrick Danahy.
View institutional ownership trends
.

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL).

Company Calendar

Last Earnings
8/12/2025
Today
8/30/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PLSE
CIK
1625101
Fax
N/A
Employees
140
Year Founded
N/A

Price Target and Rating

High Price Target
$22.00
Low Price Target
$22.00
Potential Upside/Downside
+41.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.58 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-63.19%
Return on Assets
-54.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.05
Quick Ratio
12.04

Sales & Book Value

Annual Sales
$700 thousand
Price / Sales
1,493.62
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.55 per share
Price / Book
10.03

Miscellaneous

Outstanding Shares
67,280,000
Free Float
19,174,000
Market Cap
$1.05 billion
Optionable
Optionable
Beta
1.60
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:PLSE) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners